Francesca Gaia R.
- Country
- Italy
- Department
- Ematologia
Research Overview
- Phase I-II Study of Romidepsin Combined with CHOEP for Initial Treatment in Young Patients with Nodal Peripheral T-Cell Lymphomas Prior to Hematopoietic Stem Cell Transplantation
- A Phase 2 Open-label Study of Loncastuximab Tesirine in Combination with Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Patients with Diffuse Large B-cell Lymphoma (DLBCL) (LOTIS-9)
- Evaluation of Epcoritamab in Combination with Chemotherapeutic Agents in B-cell Non-Hodgkin Lymphoma: A Phase 1b/2 Open-Label Study
Data & Insights
Has run more than one trial at 42 of 147 partner sites.
Specializations
Hematologic Malignancies
Investigation of lymphomas, leukemias, and multiple myeloma with emphasis on emerging targeted and immunotherapeutic approaches.
- Follicular Lymphoma
- Chronic Lymphocytic Leukemia
- Waldenström macroglobulinemia
- Acute Myeloid Leukemia
- Multiple Myeloma
Research addresses disease biology, resistance pathways, and outcomes after hematopoietic stem cell transplantation.
Myeloproliferative & Myelodysplastic Disorders
Focused studies on myelofibrosis, polycythemia vera, and myelodysplastic syndromes to refine risk stratification and therapeutic sequencing.
- Primary Myelofibrosis
- Post‑Polycythemia Vera Myelofibrosis
- Essential Thrombocythemia
- Myelodysplastic Syndrome with del5q
- Chronic Myeloid Leukemia
Efforts include molecular profiling and evaluation of novel JAK‑inhibitor strategies.
Liver Metabolic Disease
Clinical research on non‑alcoholic steatohepatitis (NASH) and its metabolic drivers, targeting fibrosis regression and metabolic improvement.
- Non‑Alcoholic Steatohepatitis (NASH)
- Metabolic Dysfunction‑Associated Steatohepatitis (MASH)
- Compensated Cirrhosis due to NASH
- Liver Fibrosis Regression
- Metabolic Risk Factor Modulation
Studies integrate hepatocellular outcomes with systemic metabolic health.
Autoimmune & Systemic Disorders
Exploration of therapeutic options for systemic lupus erythematosus, lupus nephritis, and related autoimmune cytopenias.
- Systemic Lupus Erythematosus (SLE)
- Lupus Nephritis
- Warm Autoimmune Hemolytic Anemia
- Immune Thrombocytopenia (ITP)
- Autoimmune Cytopenias
Research emphasizes disease activity control and organ‑preserving strategies.
Infectious Pulmonary Diseases
Targeted studies on nontuberculous mycobacterial lung infection and chronic bronchiectasis to improve antimicrobial and supportive care.
- Newly Diagnosed NTM Lung Infection (MAC)
- Bronchiectasis with Chronic Pseudomonas Colonization
- Chronic Lung Disease Management
- Respiratory Infection Prevention
- Immune‑Compromised Host Pulmonary Infections
Efforts aim to optimize treatment durability and quality of life for affected patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.